Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE)
about
Cardiac Disease and HIV in Africa: A Case for Physical Exercise.Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy.Cholesterol Screening and Statin Prescription is Low Among HIV-Infected Patients on Protease-Inhibitor Regimens in Botswana.Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.
P2860
Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE)
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@ast
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@en
type
label
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@ast
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@en
prefLabel
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@ast
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@en
P2093
P2860
P1476
Cardiovascular disease risk fa ...... Saharan Africa: A5208 (OCTANE)
@en
P2093
Agnes Moses
Douglas Shaffer
Evelyn Hogg
Fredrick Sawe
Judith Currier
Michael D Hughes
Yajing Bao
P2860
P304
P356
10.1097/QAI.0000000000000131
P407
P577
2014-06-01T00:00:00Z